KK
RXST icon

KLP Kapitalforvaltning’s RxSight RXST Stock Holding History

KLP Kapitalforvaltning’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,200
Closed -$80.6K – 2209
2025
Q2 		$80.6K Hold
6,200
– – ﹤0.01% 2093
2025
Q1 		$157K Hold
6,200
– – ﹤0.01% 1856
2024
Q4 		$213K Buy
+6,200
New +$280K ﹤0.01% 1793

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KLP Kapitalforvaltning's RXST Position: Q3 2025 in Review

KLP Kapitalforvaltning sold out of RxSight (RXST) in Q3 2025, closing a stake of 6,200 shares — an estimated $80.6K sold.

KLP Kapitalforvaltning first reported a position in RXST in Q4 2024 and held it in 3 quarters. The position peaked at $213K in Q4 2024. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

  • KLP Kapitalforvaltning reported no remaining RxSight position as of Q3 2025 after selling out during the quarter.
  • KLP Kapitalforvaltning sold 6,200 RxSight shares in Q3 2025, an estimated $80.6K.
  • KLP Kapitalforvaltning first reported a position in RxSight in Q4 2024 and held it in 3 quarters.
  • KLP Kapitalforvaltning's RxSight position peaked at $213K in Q4 2024.
  • 160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2025, filed 23 Oct 2025.